Your new experience awaits. Try the new design now and help us make it even better

CASE REPORT article

Front. Genet.

Sec. Genetics of Common and Rare Diseases

Volume 16 - 2025 | doi: 10.3389/fgene.2025.1588108

Case report: Clinical and Molecular Particularities in a Radiosensitive Autoimmune Polyendocrine Syndrome Type 1 Patient With Oral Carcinoma

Provisionally accepted
Asma  ChikhaouiAsma Chikhaoui1Houda  Hammami-GhorbelHouda Hammami-Ghorbel2Dorra  NajjarDorra Najjar1Semia  ZarraaSemia Zarraa3Safia  YahiaouiSafia Yahiaoui3Davor  LesselDavor Lessel4,5Houda  Yacoub-YoussefHouda Yacoub-Youssef1*
  • 1Laboratoire de Génomique Biomédicale et Oncogénétique, Institut Pasteur de Tunis, Tunis, Tunisia
  • 2Department of Dermatology, Habib Thameur Hospital, Tunis, Tunisia
  • 3Department of Radiotherapy, Salah Azaiez Institute, Tunis, Tunisia
  • 4Institute of Human Genetics, University of Regensburg, Regensburg, Bavaria, Germany
  • 5Institute of Clinical Human Genetics, University Hospital Regensburg, Regensburg, Germany

The final, formatted version of the article will be published soon.

Autoimmune polyendocrine syndrome type-1 (known as APECED syndrome) is an autoimmune genetic disease characterized by multiple endocrine disorders, chronic mucocutaneous candidiasis, and various ectodermal defects. Untreated candidiasis can increase the risk of oral cancer due to recurrent fungal infections. Radiotherapy is a curative option that can trigger an antitumoral response. However, exaggerated radiation-induced cytotoxicity can hinder this curative modality. APECED is caused loss of function mutations in the autoimmune regulator AIRE gene, with only a few cases reported in Tunisia. In this study, we report the clinical, genetic, and molecular characteristics of a patient with APECED syndrome. This patient was initially referred for genetic inquiry due to extreme sensitivity to radiotherapy after developing oral squamous cell carcinoma. Whole-exome sequencing (WES) was performed to identify disease-causing mutations. A set of candidate genes was further analyzed using RT-qPCR to explore the possible underlying interaction between the detected variant and altered gene expression in inflammatory pathways. We report a loss-of-function, germline, homozygous variant in the AIRE gene associated with APECED syndrome and a gain-of-function variant in MAP3K3, previously identified in patients with cerebral cavernous malformations (CCMs). Unexplained inflammatory and biochemical manifestations, including increased leucocyte, neutrophil, and C-Reactive Protein levels were noted. As MAPK signaling is organized as a three-tier cascade: MAP3Ks activate MAP2Ks, which then activate MAPKs (ERK, p38, JNK). These pathways regulate key cellular processes such as proliferation, differentiation, and stress responses, with each kinase having distinct substrate specificity Analysis of candidate gene expression interacting with the 2 key genes indicated overexpression of p38, TNFα, and STAT3, which may be associated with these manifestations. Our results underline the impact of WES in clinical diagnosis and confirm the impact of the identified variants on disease manifestation. We also suggest that the co-occurrence of APECED syndrome and a possible variant causing CCMs may be involved in the poor survival of atypical oral carcinoma cases and radiation-induced cytotoxicity.

Keywords: autoimmune polyendocrine syndrome type-1, cerebral cavernous malformations, Oral Carcinoma, radiation-induced cytotoxicity, MAP3K3, AIRE

Received: 07 Mar 2025; Accepted: 30 Sep 2025.

Copyright: © 2025 Chikhaoui, Hammami-Ghorbel, Najjar, Zarraa, Yahiaoui, Lessel and Yacoub-Youssef. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Houda Yacoub-Youssef, houda.yacoub@pasteur.utm.tn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.